GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » PB Ratio

Guizhounli Pharmaceutical Co (SHSE:603439) PB Ratio : 4.10 (As of May. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Guizhounli Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-27), Guizhounli Pharmaceutical Co's share price is ¥15.42. Guizhounli Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥3.76. Hence, Guizhounli Pharmaceutical Co's PB Ratio of today is 4.10.

Good Sign:

Guizhou Sanli Pharmaceutical Co Ltd stock PB Ratio (=4.02) is close to 5-year low of 3.84

The historical rank and industry rank for Guizhounli Pharmaceutical Co's PB Ratio or its related term are showing as below:

SHSE:603439' s PB Ratio Range Over the Past 10 Years
Min: 3.84   Med: 5.65   Max: 22.15
Current: 4.1

During the past 11 years, Guizhounli Pharmaceutical Co's highest PB Ratio was 22.15. The lowest was 3.84. And the median was 5.65.

SHSE:603439's PB Ratio is ranked worse than
69.25% of 1314 companies
in the Biotechnology industry
Industry Median: 2.525 vs SHSE:603439: 4.10

During the past 12 months, Guizhounli Pharmaceutical Co's average Book Value Per Share Growth Rate was 18.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 14.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.70% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Guizhounli Pharmaceutical Co was 26.40% per year. The lowest was -19.10% per year. And the median was 20.20% per year.

Back to Basics: PB Ratio


Guizhounli Pharmaceutical Co PB Ratio Historical Data

The historical data trend for Guizhounli Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhounli Pharmaceutical Co PB Ratio Chart

Guizhounli Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 8.40 6.29 4.55 5.26

Guizhounli Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.54 5.35 5.35 5.26 4.27

Competitive Comparison of Guizhounli Pharmaceutical Co's PB Ratio

For the Biotechnology subindustry, Guizhounli Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhounli Pharmaceutical Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guizhounli Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Guizhounli Pharmaceutical Co's PB Ratio falls into.



Guizhounli Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Guizhounli Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=15.42/3.757
=4.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Guizhounli Pharmaceutical Co  (SHSE:603439) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Guizhounli Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Guizhounli Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhounli Pharmaceutical Co (SHSE:603439) Business Description

Traded in Other Exchanges
N/A
Address
Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.
Executives
Zhang Hong Yu Directors, senior managers
Wang Yi senior management
Zhang Qian Fan Directors, senior managers
Sheng Yong Jian Director

Guizhounli Pharmaceutical Co (SHSE:603439) Headlines

No Headlines